Jiangsu Nhwa Pharmaceutical Co., Ltd.
江蘇恩華藥業股份有限公司
- Listing
- SZSE 002262
Clinical-stage assets
| Asset | Stage at source date | Indication | Source date |
|---|---|---|---|
| Sleep-disorder drug candidate | Clinical stage; phase undisclosed | Not disclosed | 2026-09-29 |
Licensing announcements since 2025
| Date | Counterparty | Asset / platform | Upfront | Near-term | Potential total | Stage at announcement |
|---|---|---|---|---|---|---|
| 2026-09-29 | Somnivera, Inc. | Sleep-disorder drug candidate | USD 10,500,000 | Not disclosed | Not disclosed | Clinical stage; phase undisclosed |